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Oral Somatic Transgene Vaccination
Using Attenuated S. typhimurium
forms of administration such as microencapsulation.
Moreover, the use of the natural route of entry could
prove to be of benefit since many bacteria, like Salmo-
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Birgit Gerstel,* Petra Wachholz,*
Kenneth N. Timmis,² JuÈ rgen Wehland,*
nella, egress from thegut lumen via the Mcells of Peyer'sTrinad Chakraborty,³ and Siegfried Weiss*
Patches (Neutra et al., 1996; Siebers and Finlay, 1996)*Division of Cell Biology and Immunology
and migrate eventually into lymph nodes and spleen,²Division of Microbiology
thus allowing targeting of vaccines to inductive sites ofGesellschaft fuÈ r Biotechnologische Forschung
the immune system.National Research Centre for Biotechnology
Genetic immunization has recently provided a promis-Mascheroder Weg 1
ing new approach to vaccination (for review, see Don-D-38124 Braunschweig
nelly et al., 1997). Isolated plasmid DNAÐintroducedGermany
into muscle or skin of the hostÐleads to expression of³ Institute for Medical Microbiology
antigen in the host cells when transcription is driven byUniversity Giessen
eukaryotic controlelements. This has ledto B- and T-cellFrankfurter Strasse 107
stimulation and to protective responses. How these re-D-35392 Giessen
sponses are generated still remains unclear. MuscleGermany
cells apparently express low levels of MHC class I, but
lack MHC class II and costimulatory molecules. Al-
though it is not known which cells function as antigen-
Summary presenting cells (APCs) under these circumstances, it
is likely that resident dendritic cells or macrophages
An attenuated strain of S. typhimurium has been used capture the antigen and migrate to lymph nodes and
as a vehicle for oral genetic immunization. Eukaryotic spleen to stimulate CD41 and CD81 T cells. Indeed,
expression vectors containing truncated genes of antigen-expressing dendritic cells have been observed
ActA andlisteriolysinÐtwo virulence factorsof Listeria following genetic immunization via the skin using a gene
monocytogenesÐhave been used to transform S. gun (Condon et al., 1996). It is not known whether DNA
typhimurium aroA. Multiple or even singleoral immuni- is also transferred directly into dendritic cells when plas-
zations with such transformants induced excellent mids are applied to muscle tissue.
cellular and humoral responses. In addition, protective Several advantages of genetic immunization over con-
immunity was induced with listeriolysin transformants. ventional vaccination have beenobserved. The DNA can
The quality of the responses suggested a transfer of be detected for a considerable period of time and thus
plasmid DNA from the bacterial carrier to the host. acts as a depot of antigen (Zhu et al., 1993). Sequence
motifs in some plasmids are immunostimulatory and canSuch transfer was unequivocally shown in vitro with
function as adjuvants (Krieg et al., 1995; Messina et al.,primary peritoneal macrophages. We describe a highly
1991; Yamamoto et al., 1992). Coexpressionof cytokinesversatile system for antigen delivery, identification of
enhances the response and offers the possibilityof mod-protective antigens for vaccination, and efficient gen-
ulating the induction of an immune response into a de-eration of antibodies against the product of open read-
sired direction (Xiang and Ertl, 1995; Geissler et al., 1997;ing frames present on virtually any DNA segment.
Kim et al., 1997). Despite this, several obstacles need
to be overcome before general applicability can be
achieved.Introduction
If it were possible to deliver plasmids for genetic im-
munization with an attenuated bacterial carrier, the ad-The design of efficient vaccines against infectious dis-
vantages and versatilities of both systems could beeases remains a major challenge in medical science.
combined. In addition, the natural route of administra-Low cost, noninvasive administration, life-long pro-
tion would deliver DNA to cell types that have specifi-tection by single doses combined with ease of prepara-
cally evolved to induce immune responses. Salmonellation, storage, and transport are desirable goals to be
spp. are particularly suited for this purpose because ofachieved. In this respect, live, attenuated bacterial carri-
the extensive knowledge onthe genetics and physiologyers that express heterologous antigens are attractive
of many strains. A large body of documentation alreadyvehicles for the oral delivery of vaccines. This type of
exists pertaining to their utility as heterologous antigendelivery should result in a broad spectrum of both muco-
carriers capable of inducing protective immune re-
sal and systemic immune responses. While oral subunit
sponses (Newton et al., 1989; Fairweather et al., 1990;
vaccines usually need to be coadministered with adju-
reviewed by Chatfield et al., 1994; Roberts et al., 1994).
vant proteins, such as cholera toxin, to evoke an effec- Safe attenuated strains of Salmonella are available and
tive immune response (Brown et al., 1987; Flynn et al., are already in use as vaccines in man and farm animals
1990), live replicating vectors produce their own immu- (Germanier and FuÈ rer, 1975; Hassan, 1996; Steinbach,
nomodulatory factors (e.g., cell-wall components) in 1996; Fox, 1997). Finally, recombinant plasmids con-
situ, which also constitutes an advantage over other structed in laboratory strains of E. coli can be directly
introduced into salmonellae without further manipu-
lation.§To whom correspondence should be addressed.
Cell
766
Here, we report that orally administered attenuated recombinant salmonellae and their cytotoxic T-cell re-
sponses followed for several weeks by testing theirSalmonella typhimurium aroA bacteria carrying plas-
spleen cells directly ex vivo (data not shown) or aftermids containing the coding sequences of b-galactosi-
one restimulation in vitro. Alternatively, mice were orallydase (b-gal) of Escherichia coli , or truncated forms of
immunized four times at 2 week intervals and the courseActA or listeriolysin of Listeria monocytogenes, each
of the cytotoxic response was examined. Figure 1 dem-under the control of an eukaryotic promoter, induce
onstrates that a strong and specific CD8 T-cell responseefficient humoral and cellular immune responses. The
was elicited with the orally administered Salmonella car-strength and kinetics of the responses is only compati-
rying eukaryotic expression plasmids. Mice immunizedble with the interpretation of a transfer of the expression
with the truncated gene of listeriolysin elicited a re-plasmid from the Salmonella carrier to the nucleus of
sponse only toward targets sensitized with the immuno-APCs of the host. b-galactosidase activity was detect-
dominant peptide comprising aa 91±99 of listeriolysinable 5 weeks after administration of the oral vaccine.
(LLO) and not against targets sensitized with solubleIn addition, in vitro experiments with mouse primary
hen egg lysozyme (HEL) or a control peptide (Figuremacrophages demonstrated anefficient transfer of plas-
1A). Similarly, spleen cells from mice immunized withmid DNA from attenuated bacteria into the nucleus of
Salmonella carrying the ActA expression plasmid couldthe phagocytic host cells.
only respond to ActA (Figure 1D). To reveal the cytotoxic
response against ActA, we exploited the pore-forming
Results activity of listeriolysin. This activity of listeriolysin allows
the introduction of soluble passenger proteins into the
To achieve genetic immunization with a live, attenuated cytosol of target cells (Darji et al., 1995a, 1997). Stimula-
bacterial carrier, three plasmids based on the commer- tors and target cells were therefore sensitized with a
cially available plasmid pCMVb were used. This plasmid mixture of soluble ActA and LLO. A specific response
contains the structural gene of b-gal under the control was observed only when the combination of ActA and
of the human CMV immediate-early promoter and in- LLO was used. No response was found when LLO alone
cludes a splice donor and two splice acceptor sites was tested. These responses were specific for the plas-
between the promotor and the structural gene. For stud- mid-encoded antigen during the entire time period indi-
ies examining the efficiency of the immune response cated in Figures 1B & 1C and 1E & 1F, and were also
against pathogens, the b-gal gene was substitued by observed when the responses of mice immunized with
genes encoding two virulence factors of Listeria mono- Salmonella harboring the b-gal control plasmid was
cytogenes: a truncated gene encoding a nonhemolytic studied (data not shown).
variant of the listeriolysin protein (pCMVhly) consisting The kinetics of the responses indicated that even a
single dose elicited a strong cytotoxic T-cell responseof amino acids (aa) 26±482, and a truncated gene of
that peaked 5 weeks after immunization and then slowlythe membrane protein ActA (pCMVactA) encoding aa
declined (Figures 1C and 1F). On the other hand, the31±613, were used. The S. typhimurium aroA strain
response was still rising even at the end of the observa-SL7207 was transformed with these three plasmids, and
tion period, i.e., 5 weeks after the last booster dose, ingroups of mice were orally immunized by feeding 108
mice that had received four doses (Figures 1B and 1E).organisms to each mouse per immunization. This dose
Thus, a strong cytotoxic response was observed withwas found to be optimal (data not shown). None of the
Salmonella as a vehicle for genetic immunization.mice showed any overt signs of illness during immuni-
Genetic immunization in addition usually evokes azation.
CD4 helper-T-cell response (Donnelly et al., 1997).
Therefore, cells from spleens and mesenteric lymph
Induction of a Strong T-Cell Response by nodes of the same mice used above were tested for
Immunization with Salmonellae Carrying their proliferative response against soluble proteins.
Eukaryotic Expression Vectors This type of response is mainly due to presentation of
These experiments were based on theworking hypothe- antigen via MHC class II molecules and is carried out
sis that orally administered S. typhimurium aroA would by CD4 T cells. As shown in Figure 2, a strong and
result in uptake of the bacteria by macrophages and/or specific helper-T-cell response, which paralleled the cy-
dendritic cells, with concomitant activation by bacterial totoxic response, was observed when eukaryotic ex-
endotoxin. After a few rounds of division, intracellular pression plasmids carried by salmonellae were used
bacteria would die because of their inability to synthe- for immunization (Figures 2A and 2D). As with the CD8
size essential aromatic amino acids. During this pro- response, a single dose was sufficient for a good re-
cess, plasmids would be released and transferred into sponse that was still increasing at the end of the obser-
the cytosol and the nucleus of the infected cells. Eventu- vation period, regardless of whether listeriolysin or ActA
ally, the encoded genes would be expressed by host was used as antigen (Figures 2C and 2F). Four con-
APCs. secutive immunizations, however, resulted in an even
The first prediction of this hypothesis is that there stronger response that appeared to be long-lasting
should be a strong induction of cytotoxic CD8 T cells, since it apparently was still increasing 5 weeks after the
since antigen would be expressed in the cytosol, the last booster (Figures 2B and 2E). Similar results were
cellular compartment responsible for MHC class I pre- obtained with Salmonella carrying the control plasmid
sentation. To this end, two kinds of experiments were expressing b-gal (data not shown). Analysisof the super-
natants of the in vitro cultures revealed production ofperformed. Mice were either orally infected once with
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Figure 1. Induction of Cytotoxic T Cells in Mice Orally Immunized with S. typhimurium aroA Carrying Eukaryotic Expression Plasmids Encoding
Listeriolysin or ActA Fragments
Mice were immunized with 108 bacteria either four times at 2 week intervals (A, B, D, and E) or once (C and F) with Salmonella carrying
pCMVhly (A±C) or pCMVactA (D±F). Spleen cells were restimulated once in vitro with a synthetic peptide comprising aa 91±99 of listeriolysin
(A±C) or with a mixture of purified ActA and hemolytically active listeriolysin, which results in the class I presentation of ActA due to the pore-
forming activity of listeriolysin (Darji et al., 1995a, 1997). Restimulated T cells were tested with radiolabeled P815 target cells at an effector-
to-target ratio of 10:1. (A) Specificity of the anti-listeriolysin cytotoxic response. Target cells were sensitized with hen egg lysozyme (HEL),
peptide aa 91±99 of listeriolysin (pLLO), or control peptide aa 147±155 of nucleoprotein of influenza virus (pNP). Displayed is the experiment
with spleen cells from week 5 shown in (B). Similar specificity was observed at all other time points.
(B) Kinetics of the cytotoxic response of mice immunized four times with pCMVhly. The arrows indicate the booster immunizations.
(C) Kinetics of the cytotoxic response of mice immunized once with pCMVhly.
(D) Specificity of the anti-ActA cytotoxic response. Target cells were sensitized with a mixture of ActA and listeriolysin (ActA 1 LLO), HEL
and listeriolysin (HEL 1 LLO), or listeriolysin alone (LLO). Displayed is the experiment with restimulated spleen cells from week 5 shown in
(E). Similar specificity was observed at other time points and including other synthetic peptides of various sources.
(E) Kinetics of the cytotoxic T-cell response in mice immunized four times with pCMVactA. Arrows indicate booster immunizations.
(F) Kinetics of the cytotoxic T-cell response in mice immunized once with pCMVactA. The specificity of the cytotoxic response was further
assessed by testing the spleen cells of mice immunized in a similar way with pCMVb (b-gal) on target cells sensitized with pLLO, ActA plus
listeriolysin, or a b-gal-expressing transfectant of P815 (data not shown). Similarly, a specific cytotoxic T-cell response was observed against
b-gal, but the kinetic was not followed as systematically as for the two other antigens.
IFNg by these T cells. No IL-4 was found, which suggests lasting response since the plateau of antibody titers was
maintained even at the end of the observation periodthat such an immunization scheme mainly induces a
Th1 or inflammatory type of T-helper response. (Figures 3A and 3B).
Analysis of the IgG subclass distribution in the im-
mune sera of individual mice at week 11 indicated aInduction of Specific Antibodies by Immunization
high concentration of IgG2a, while the concentrationswith Salmonellae Carrying Eukaryotic
of IgG2b and IgG3 were negligible (Figures 3C and 3D).Expression Vectors
This is in agreement with the finding that only IFNg andPooled sera of the groups of mice used above were
no IL-4 could be detected in the supernatants of thetested for the presence of specific antibodies. Clearly,
restimulated T-helper cells. However, IgG1 was also ob-in addition to a cytotoxic and helper-T-cell response,
served at high concentrations in the immune sera. Thisimmunization with salmonellae carrying eukaryotic ex-
subclass is found when Th2-helper cells participate inpression plasmids induced strong and specific antibody
the immune response (Mosmann and Coffman, 1989),responses as revealed by ELISA (Figures 3A and 3B) or
which indicates that under our experimental conditionsimmunoblot (data not shown). Again, a single immuniza-
Th2 cells might also be induced but were not revealedtion was sufficient for a good response that peaked 4
in the in vitro T-cell assay. In addition, serum IgA anti-weeks after the administration of the bacteria and then
bodies were evoked by this immunization schedule (datadeclined in the same way as seen for the cytotoxic re-
not shown).sponse. Four immunizations did not increase the anti-
body titer significantly but probably induced a longer Taken together, the results presented in Figures 1±3
Cell
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Figure 2. Induction of Helper-T Cells
Spleen (SPC) and lymph node cells (LNC) from the same mice tested for cytotoxic T-cell responses described in Figure 1 were tested for
T-helper responses. Mice were immunized either four times (A, B, D, and E) or once (C and F) with 108 Salmonella carrying pCMVhly (A±C) or
pCMVactA (D and F) and restimulated in vitro. After 2 days, proliferation was tested by incorporation of 3H-Thymidine.
(A) Specificity of the proliferative response of spleen cells from mice immunized with pCMVhly. T cells tested were the same as those displayed
in (B) at week 11. Similar results were obtained at other time points.
(B) Kinetics of the proliferative response of spleen and lymph node cells from mice immunized four times with pCMVhly. Arrows indicate the
booster immunizations.
(C) Kinetics of the proliferative response of spleen and lymph node cells from mice immunized once with pCMVhly.
(D) Specificity of the proliferative response of spleen cells from mice immunized four times with pCMVactA. T cells tested were the same as
those displayed in (D) at week 11. Similar results were obtained at other time points.
(E) Kinetics of the proliferative response of spleen and lymph node cells immunized four times with pCMVactA. Arrows indicate booster
immunizations.
(F) Kinetics of the proliferative response of spleen and lymph node cells from mice immunized once with pCMVactA. Spleen and lymph node
cells from mice immunized with pCMVb (b-gal) never reacted with either listeriolysin or ActA but could respond to restimulation with b-gal
(data not shown).
show that immunization with S. typhimurium aroA time of termination of the experiment. All animals that
were immunized with salmonellae that carried the b-galcarrying eukaryotic expression vectors can evoke re-
sponses in all three specific effector compartments of control plasmid were not protected and died within four
days. Perhaps surprisingly, immunizations with salmo-the immune system, namely, cytotoxic CD8 T cells, CD4
T cells, and antibodies. The response in the T-helper nellae carrying the ActA expression plasmid did not re-
sult in protection, although strong cytotoxic and helper-compartment was strongly biased toward a Th1- or in-
flammatory T-helper response. T-cell responses could be demonstrated in such mice,
indicating that the immunization had been successful
(data not shown). Thus, the listerial membrane proteinProtection against Lethal Doses
of L. monocytogenes ActA is not a protective antigen.
The strong responses observed above, in particular that
of cytotoxic T cells, suggested that mice immunized in Evidence for Transfer of the Expression Plasmid
from the Carrier Salmonellae to Host Cells In Vivothis way should be protected from a lethal dose of L.
monocytogenes. Therefore, 90 days after the first immu- We were concerned that a weak activity of theeukaryotic
promoter in the host bacteria or a cryptic prokaryoticnization or 48 days after the fourth immunization (where
applicable) mice were challenged intravenously with a promoter in the plasmid might have resulted in expres-
sion of the antigens in the bacterial carrier, thereby elic-dose of bacteria corresponding to 10 3 LD50. Figure
4 shows that animals that were immunized four times iting the potent immune response. In fact, the recombi-
nant salmonellae harboring the pCMVb exhibited lowconsecutively with salmonellae harboring a eukaryotic
expression vector that encodes truncated LLO were b-gal activity (2.5 U) compared to the parental strain.
To assess this possibility, we immunized mice with acompletely protected (Figure 4A). Animals that had re-
ceived only a single vaccination were significantly pro- recombinant Salmonella strain that produced more than
100-fold higher levels (334 U) of b-gal enzymatic activity.tected, and 60% of the animals were still alive at the
Oral Genetic Vaccination
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Figure 4. Protective Immune Response after Oral Genetic Immuni-
zation
Groups of six mice were immunized four times at 2 week intervals
(A) or only once (B) with Salmonella carrying pCMVhly, pCMVactA,
or pCMVb and challenged intravenously with a lethal dose of 5 3
104 L. monocytogenes EGD (10 3 LD50). Mice that had been immu-
nized only once with pCMVhly showed signs of distress one day
after injection and two died 3 days later, whereas the remaining four
recovered and survived in good condition until the experiment was
terminated 2 weeks later.
staining was diffuse and clearly not restricted to the
Figure 3. Kinetics and Subclass Distribution of Specific Serum IgG endocytic vesicles in which salmonellae usually reside.
Sera from the same mice tested for cytotoxic and proliferative T-cell This suggests that plasmid DNA was efficiently trans-
responses described in Figures 1 and 2 were used and assayed in
ferred from dying salmonellae to host cells.specific ELISAs. Mice were immunized four times (A) or once (B)
with pCMVhly, pCMVactA, or pCMVb, respectively, and pooled sera
DNA Transfer from S. typhimurium aroAwere tested for antigen-specific serum IgG. To assess specificity, all
sera were tested on all three antigens. Reactivity was only observed to Mammalian Host Cells In Vitro
against the immunizing antigen (data not shown). Identical results To obtain direct evidence that DNA transfer from the
were obtained by immunoblotting using the same antigens (data bacterial carrier to the mouse macrophages can take
not shown). The subclass distribution 11 weeks after the first immu-
place, primary peritoneal macrophages were infectednization was determined from the sera of individual mice immunized
in vitro for 1 hr with salmonellae harboring the b-galfour times (closed symbols) or once (open symbols) with either
expression plasmid (pCMVb), after which gentamicinpCMVhly (C) or pCMVactA (D).
was added to kill remaining extracellular bacteria. Tetra-
cycline was added 4 hr later to kill any viable intracellular
bacteria. After overnight incubation, cells were stainedA single vaccinating dose using these bacteria did not
elicit any measurable T-cell or antibody responses (Fig- for b-gal activity. Up to 30% of the adherent, macro-
phage-like cells exhibited b-gal activity despite the con-ures 5A±5C). Repeated vaccination, however, resulted
in a weak cytotoxic T-cell response, detectable after tinuous presence of tetracycline that blocks bacterial
protein synthesis (Figure 6).in vitro restimulation, although it barely reached the
strength of the response observed using a single immu- To rigorouslously demonstrate that b-galactosidase
was synthesized de novo by the host cell, and not bynization with salmonellae harboring the b-gal eukaryotic
expression plasmid (Figure 5A). Neither a CD4 T cell nor the bacterial vector, two types of experiments were per-
formed. First, adherent peritoneal cells were infectedan antibody response was observed, even after re-
peated oral immunization with salmonellae constitu- and treated as described above. After overnight incuba-
tion, RNA was extracted. If the plasmid had indeed beentively expressing b-gal (Figures 5B and 5C).
As a result of the aroA mutation, bacteria do not ap- transferred and transcribed in the nucleus of the host
cell, RNA splice products derived from the splice donorpear to survive very long since live bacteria could never
be recovered from immunized animals at the various and acceptor sites within the vector should be demon-
strable. By means of RT±PCR with a primer pair thattime points examined. Nevertheless, b-gal activity was
detected in adherent cellsÐmost likely macrophagesÐ hybridizes to sequences on either side of the small in-
tron, a PCR product was obtained that correspondedfrom the spleen of mice 5 weeks after oral administration
of salmonellae harboring the eukaryotic b-gal expres- to one of the expected splice products (Figure 7A). The
identity of this product was confirmed by DNA sequenc-sion plasmid, which suggests that plasmid transfer to
the eukaryotic cell had taken place (data not shown). ing (data not shown). Second, biosynthetic labeling of
proteins in thepresence of tetracycline should only allowTo extend this observation, we injected salmonellae car-
rying the pCMVb vector into the peritoneum of mice and translation of mRNA produced by the eukaryotic host
cells. Adherent peritoneal cells were infected as de-harvested the peritoneal exudate after 1 hr. Subse-
quently, cells were cultured overnight in the presence scribed and were pulsed for 30 min with 35S-methionine
after 4, 24, or 48 hr in theabsence or presence of tetracy-of tetracycline to inhibit bacterial protein synthesis and
then stained for b-gal activity. b-gal activity was ob- cline. At 4 hr, no b-gal could be observed by immunopre-
cipitation, even in the absence of tetracycline whereserved in a large number of macrophage-like cells. The
Cell
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Figure 5. Comparison of Orally Induced Immune Responses Elicited with Salmonella Harboring Prokaryotic or Eukaryotic b-Gal Expression
Plasmids
Mice were immunized with Salmonella harboring either the eukaryotic expression plasmid pCMVb or the plasmid pAH97 that constitutively
expressed b-gal from the Pr and Ps promotors of xylS of Pseudomonas putida. Bacteria harboring the eukaryotic vector were administered
orally once (closed circles), whereas bacteria expressing b-gal under the control of the prokaryotic promotor were administered either once
(closed diamonds) or four times with 2 week intervals (closed upside-down triangles). The arrows indicate the time of booster immunizations.
(A) Cytotoxic response of restimulated spleen cells tested at an effector-to-target ratio of 10:1. The b-gal-expressing transfectant P13.1 was
used as target in the JAM assay.
(B) Proliferative helper-T-cell response of spleen cells with isolated b-gal as antigen.
(C) Antibody response against b-gal from pooled sera measured by ELISA. Data displayed in (A)±(C) were obtained with cells or sera from
the same mice. All assays were performed as described in Figures 1±3.
bacterial products should have been labeled (Figure 7B). originally carried the expression plasmid. Thus, a trans-
fer of the plasmid from salmonellae to the host cell mustThus, transfer of plasmid DNA and eukaryotic expres-
sion had not yet taken place. However, b-gal could be have taken place.
immunoprecipitated after 24 or 48 hr of incubation, even
when tetracycline was continuously present during both
Discussionthe incubation and labeling period. Preincubation of the
anti-b-gal antibody with an excess of unlabeled b-gal
The transfer of eukaryotic expression plasmids from at-demonstrated the specificity of the immunoprecipitation
tenuated enteric bacteria into the nucleus of host cells(Figure 7B, lane 10). This clearly indicates that the pre-
has recently been demonstrated. Auxotrophic mutantscipitated b-gal was produced by the infected mamma-
of Shigella and E. coli that express the invasin of Shigellalian host cell itself and not by the bacterium that had
can introduce eukaryotic expression plasmids into host
cells (Courvalin et al., 1995; Sizemore et al., 1995). Given
that both bacteria are capable of escaping from the
phagolysosome into the cytosol of the host cell, it fol-
lows that lysis of bacteria in this compartment would
allow transfer of the released plasmid DNA into the nu-
cleus. Transfer of plasmid from intracellular pathogens
such as Salmonella would be harder to imagine, as these
bacteria are generally retained within vacuoles of the
infected host cell. Indeed, only a ªlow efficiencyº of
plasmid transfer into a macrophage cell line using atten-
uated Salmonella had been reported (Sizemore et al.,
1995). Our initial experiments using several macrophage
Figure 6. Expression of b-Gal Activity in Peritoneal Exudate Cells cell lines confirmed this observation (data not shown).
Freshly isolated peritoneal exudate cells (PECs) were allowed to However, the kinetics and strength of the immune
adhere for 2 hr and were infected at an MOI of 10 for 15 min with response elicited by administration of Salmonella car-
Salmonella bearing pCMVb in antibiotic-free medium. Following a
rying eukaryotic expression vectors, which we observedwash and addition of gentamycin to kill extracellular bacteria, incu-
here, suggested that a plasmid transfer can take placebation was continued for 3±4 hr at 378C, and tetracycline was then
added to the medium to kill any viable bacteria by blocking their in vivo. We therefore decided to investigate primary
protein synthesis. After 24 hr, expression of b-gal activity in up to macrophages isolated from the peritoneum of mice.
30% of the adherent cell population was observed. Only macro- Compelling evidence for a transfer of plasmid DNA from
phage-like cells expressed enzymatic activity. The small cells found Salmonella to the host cell in vitro was obtained. Both
in the cultures most likely represent nonadherent lymphocytes that
the splicing of RNA, and protein synthesis in the pres-were not removed in this particular experiment. Staining the cells
ence of tetracycline, are only possible if the gene isat the time of addition of tetracyclin did not reveal any enzymatic
activity. expressed by the eukaryotic host cell. Evidence that
Oral Genetic Vaccination
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lines suggests the presence of a transport pathway that
only operates efficiently in primary cells.
Strong cytotoxic and protective responses toantigens
delivered by Salmonella have only been reported with
Salmonella recombinants that secrete the antigens; no
comparable responses have been reported using Sal-
monella that constitutivelyexpress nonsecreted heterol-
ogous proteins (Hess et al., 1996). Turner et al. (1993)
have demonstrated that high doses of recombinant bac-
teria expressing intracellular protein are required to in-
duce CD8 T cells. Although induction of specific anti-
bodies has been described under some experimental
conditions (GuzmaÂn et al., 1991; Walker et al., 1992), noFigure 7. The Eukaryotic Host Cells Transcribe and Translate the
b-Gal Gene Derived from S. typhimurium aroA Harboring theExpres- antibody response was observed under the experimen-
sion Plasmid tal conditions used by Turner et al. (1993). This was
(A) RNA derived from PECs 24 hr after infection with Salmonella confirmed by our own results (Figure 5). We therefore
carrying pCMVb was analyzed by RT±PCR. A primer pair that bor- consider it to be highly unlikely that the strong cytotoxic
ders the splice donor and acceptor sites downstream of the promo- and helper-T-cell responses and specific antibody pro-
tor was used. In lane 2, a band of 196 bp (indicated by the arrow)
duction are the results of any fortuitous expression ofwas detected. DNA sequencing identified this fragment as a splice
the antigens in the Salmonella carrier.product. The stronger 227 bp fragment seen in this lane is either
due to carryover of DNA into theRNA preparation ordue to inefficient The strength of the immune response observed, even
splicing. Lane 1 shows the untreated macrophage control, and the with a single immunization, indicates that transfer of
lane marked (M) contains the molecular size marker used. Since DNA by bacterial carrier is probably superior to that
the signal of the splice product was extremely weak, we inverted the achieved by direct application of isolated plasmid DNA
colors from white to black. This resulted in an increase of contrast
into skin or muscle. This suggests that by using theand allowed the visualization of the splice product on the graph.
natural port of entry of a pathogen, theexpression vector(B) PECs were infected with pCMVb carrying Salmonella as de-
scribed and, after incubation for various lengths of time, biosynthetic is transferred into cell types that have evolved to effi-
labeling was performed with 35S-methionine in the presence or ab- ciently induce an immune response. It is likely that the
sence of tetracycline, followed by immunoprecipitation with b-gal- Salmonella carrier is taken up by macrophages and den-
specific monoclonal antibodies. Controls: (1) BHK cells; (2) BHK dritic cells. Whether macrophages play a role during
cells transfected with b-gal (positive control). Infected PECs: (3)
stimulation of naive T cells against bacteria is not clear,incubated 4 hr postinfection without tetracycline; (4) incubated 4 hr
but dendritic cells are known to be highly efficient inpostinfection with tetracycline during labeling; (5) incubated 4 hr
postinfection with tetracycline during incubation and labeling; (6) priming resting T cells. Since the antigen is expressed
incubated 24 hr postinfection without tetracycline; (7) incubated 24 in the cytosol of these cells, a strong cytotoxic T-cell
hours postinfection with tetracycline during labeling; (8) incubated response is to be expected.
24 hr postinfection with tetracycline during incubation and labeling The induction of strong helper and antibody response
(9) incubated 48 hr postinfection without tetracycline; (10) incubated
is puzzling and can presently only be speculated upon.48 hr postinfection with tetracycline during labeling. In this case, a
Some cytosolic proteins can be efficiently presented100-fold excess of unlabeled b-gal over the precipitating antibody
was added to the lysate before immunoprecipitation; (11) incubation by MHC class II molecules (Jaraquemada et al., 1990;
of 48 hr postinfection with tetracycline during labeling; (12) incuba- Brooks and McCluskey, 1993). However, it would be
tion 48 hr postinfection with tetracycline during incubation and label- very fortuitous if all three proteins used in the present
ing. No specific band was observed after 4 hr of incubation under
study display this property. In any case, it could notany conditions. However, after allowing 24 hr or more for a DNA
explain the antibody responses that we observed.transfer and expression to occur, a specificband for b-gal (indicated
Our interpretation of oral genetic immunization usingby the arrow) can be observed.
attenuated salmonellae as carrier is schematically de-
picted in Figure 8. Salmonella enter the host via M cells
transfer of the expression vector in vivo is responsible in the intestine. The bacteria are taken up in the dome
for induction of the strong immune response observed areas by phagocytic cells such as macrophages and
was also obtained. Although viable Salmonella could dendritic cells. These cells are activated bythe pathogen
not be isolated one week after the last booster, b-gal and start to differentiate and probably to migrate into
activity was observed in some adherent cells 5 weeks lymph nodes and spleen. During this period, the bacteria
later, which suggests that b-gal expression cannot be die due to their attenuating mutation and liberate the
due to residual surviving Salmonella. It is, however, plasmid-based eukaryotic expression vectors. The plas-
intriguing how such antigen-expressing cells can coex- mids are then transferred into the cytosol either via a
ist in the presence of specific cytotoxic T cells. specific transport system or by endosomal leakage. Fi-
A pathway that permits transfer of proteins from endo- nally, the vector enters the nucleus and is transcribed,
cytic vesicles into the cytosol of some cell types, includ- leading to antigen expression in the cytosol of the host
ing macrophages, has been described (Reis de Sousa cells. Specific cytotoxic T cells are induced by these
and Germain, 1995; Norbury et al., 1995). Whether or activated APCs that lyse antigen-expressing cells. Free
not such a pathway is also responsible for the transfer antigen or dying cells are taken up by other APCs, which
of nucleic acids reported here remains to be clarified. in turn stimulate helper cells. Free antigen would also be
The fact that plasmid transfer with Salmonella was only responsible for the induction of an antibody response.
Bacterial endotoxin and DNA sequence motifs of theobserved with primary macrophages and not with cell
Cell
772
Figure 8. Schematic Representation of the Sequence of Events Assumed to Occur In Vivo after Oral Genetic Immunization with Attenuated
S. typhimurium aroA
See text for further details.
vector may also function as adjuvant and could contrib- of the ActA protein by host kinases following infection
may affect its ability to be processed). Nevertheless, theute to the strength of the responses observed.
The helper-T-cell response induced with this type of role of bacterial surface-bound proteins in protection
can easily be addressed now using the salmonellae sys-genetic immunization seemed strongly biased toward
the Th1 type as indicated by IFNg production of restimu- tem for genetic vaccination.
The induction of a strong and specific antibody re-lated T cells in vitro and the high titer of IgG2a in the
humoral response (Mosmann and Coffman, 1989). This sponse that can be measured in ELISA and by immu-
noblot revealedadditional benefits derived from the typeis not unexpected since bacteria usually induce inflam-
matory types of response. For many vaccination strate- of immunization described here. Our results suggest
that it may be possible to insert practically any opengies, it is desirable to induce a Th1 response for protec-
tion against the correseponding pathogen. For example, reading frame into a eukaryotic expression plasmid and
use Salmonella to deliver it to mice to raise high titer-strains of mice that respond with Th2 cells against Leish-
mania major do not clear the parasite and are not pro- specific polyclonal and possibly also monoclonal anti-
bodies. This will facilitate the characterization of genetected, whereas mice that mount a Th1 response are
resistant (Sher and Coffman, 1992). On the other hand, products where only sequence information is available.
The possibility of genetic immunization with DNA frag-induction of a Th2 type response or the conversion of
a Th1 response into a Th2 response has been shown to ments containing open reading frames will allow re-
searchers to define the function of new gene products,be advantageous in inflammatory autoimmune diseases
(Tian et al., 1996). Similarly, infections by nematodes provide novel serological reagents, and permit delinea-
tion and assess efficacies of protective antigens in vac-might also require a Th2 response (Sher and Coffman,
1992). Since thebacteria are only being used as a vehicle cination protocols.
In conclusion, attenuated Salmonella that carry eu-to transfer the expression plasmids, and therefore play
only a secondary role, it should be possible to manipu- karyotic expression vectors can be used for genetic
immunization via the oral route. The stimulation of cyto-late the Th1 response. The induction of specific IgG1
suggests the presence of a Th2 component during the toxic and helper T cells as well as the induction of a
strong antibody response provides a very versatile sys-helper response that might be augmentable. Coexpres-
sion of the antigen together with certain cytokines or tem for new immunization strategies. The strength of
this approach also draws on the development of newer,costimulatory molecules, or exploitation of antisense
strategies to suppress costimulatory molecules, should more rationally attenuated salmonellae strains as well
make it possible to drive the responses more toward Th2. as technical advances in providing conditional and tar-
Two well-characterized virulence factors were tested geted eukaryotic expression by the infected host cell.
as antigens for protection against a lethal challenge with
L. monocytogenes. Listeriolysin has been shown before
Experimental Proceduresto induce protection (Harty and Bevan, 1992; Hess et
al., 1996). This was also true under our experimental
Miceconditions. Interestingly, even a single dose of salmonel-
6- to 8-week-old female BALB/c (H-2d) mice were used.
lae harboring the eukaryotic listeriolysin expression
plasmid was sufficient to afford 60% of the mice protec-
tion against a lethal challenge. On the other hand, de- Media, Reagents, and Antigens
Cells were cultured in RPMI/10% fetal bovine serum. Solid and liquidspite the strong ActA-specific cytotoxic, helper, and an-
Luria Bertani medium (LB, Sambrook) was used to grow E. coli andtibody responses induced by the pCMVactA vector, no
S. typhimurium strains. Brain heart infusion broth or agar (BHI; Difco,protection was elicited. ActA is thus not a protective
Detroit, MI) was used to grow L. monocytogenes. Media were sup-antigen in this system. The membrane protein ActA on
plemented, where required with 100 mg/ml of ampicillin. Listeriolysin
challenge bacteria is obviously not available to the pre- was purified as described (Darji et al., 1995b). Soluble ActA protein
sentation mechanisms as long as the bacteria are alive (aa 31±505) was purified from supernatants of recombinant L. mono-
cytogenes.(Darji et al., submitted) (e.g., extensive phosphorylation
Oral Genetic Vaccination
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Bacterial Strains and Plasmids Detection of b-Gal Activity
Expression of b-gal in host cells was monitored by incubating theThe E. coli strain XL1-Blue (Strategene, Heidelberg, Germany) was
used as a host during the cloning experiments and to propagate fixed cells with the indicator substrate X-gal. Briefly, isolated perito-
neal macrophages were allowed to adhere for 1±2 hr at 378C in a 24-plasmids. The auxotrophic S. typhimurium aroA strain SL7207 (S.
typhimurium 2337±65 derivative hisG46,DEL407 [aroA::Tn10{Tc-s}]), well plate in antibiotic-free medium. After removing the nonadherent
cells and washing with antibiotic-free medium, S. typhimurium aroAkindly provided by Dr. B. A. D. Stocker, Stanford, CA, was used
as a carrier for the in vivo studies. L. monocytogenes strain EGD harboring the eukaryotic expression vector pCMVb were added to
the cells at a MOI of 10 and incubated at 378C for 15±30 min. Cells(serotype 1/2a; Chakraborty et al., 1992) was used for in vivo protec-
tion assays and for preparation of genomic DNA to clone actA and were washed again, and bacteria remaining extracellular were killed
by addition of medium containing 50 mg/ml gentamicin. Followinghly genes. The eukaryotic expression vector pCMVb (Clontech, Palo
Alto, CA) was used for cloning a truncated variant of actA or hly. 4 hr of incubation at 378C, 10 mg/ml of tetracycline was added to
some of the cultures to block the intracellular bacterial multiplica-For expression of b-gal in salmonellae, the plasmid pAH97 was used
(Holtel et al., 1992). It contains the Pr and Ps promotor of the xylS tion, and incubation was continued for another 24 hr. After 2±3
washes with PBS, cells were fixed with acetone/methanol (1:1 v/v)gene of Pseudomonas putida and results in constitutive expression
of b-gal (384 U) in the S. typhimurium aroA strain. and freshly prepared X-gal substrate (5 mM potassium ferrocyanide,
5 mM potassium ferricyanide, 2 mM MgCl2 and 100 mg/ml X-gal in
PBS) was added. After overnight incubation at 378C, b-gal-express-Recombinant DNA Techniques
ing cells were detected by light microscopy. Quantitation of b-galDNA preparation, genetic manipulations, PCR, and transformation
enzymatic activity in recombinant bacteria was determined ac-of bacteria were carried out according to standard protocols (Sam-
cording to standard procedures (Sambrook et al., 1982). Back-brook et al., 1982; Hanahan, 1983; O'Callaghan and Charbit, 1990).
ground (4U) was substracted from the experimental values.
Cloning of actA and hly into the Eukaryotic
Expression Vector pCMVb RNA Isolation and RT±PCR
For the construction of the eukaryotic expression vector pCMVactA, To test for expression of b-gal transferred into the eukaryotic host
a 1.8 kb fragment encoding aa 31±613 of an ActA polypeptide with- cells via Salmonella, the mRNA was probed for the presence of
out the membrane anchor (Domann et al., 1992) was amplified by splice products derived from the splice donor and acceptors of the
PCR using primers: 59-ATAAGAATGCGGCCGCCATGGCGACAGAT expression plasmid. To this end, PECs were infected in vitro at
AGCGAAGATTCTAGTC-39 and 59-ATAAGAATGCGGCCGCTTACGT an MOI of 10 with S. typhimurium aroA harboring the eukaryotic
CGTATGGTTCCCTGGTTCTTC-39. In a similar way, recombinant expression vector pCMVb and isolaton of RNA, and RT±PCR was
plasmid pCMVhly was constructed. A 1.4 kb fragment encoding a performed according to standard protocols (Chomczynski and Sac-
non-hemolytic variant comprising aa 26±482 of hly (Mengaud et al., chi, 1987; Wiles, 1993). PCR was performed for 35 cycles of 20 s
1988) was amplified using primers: 59-ATAAGAATGCGGCCGCCAT 958C, 30 s 608C, and 30 s 728C. The primer pair was designed in
GGATGCATCTGCATTCAATAAAGAAAATTC-39 and 59-ATAAGAAT such a way that the presence of splice products should be indicated
GCGGCCGCTTATTTAGCGTAAACATTAATATTTCT CGCG-39. PCR by a 190 bp and/or a 125 bp fragment. Primers used: SV40f, 59-
primers contain NotI flanking restriction sites (underlined). Start and GGATCCGGTACTCGAGGAAC-39; SV40r, 59-GCTTTAGCAGGCTCT
stop codons were also introduced (ATG and TTA in bold). pCMVactA TTCG-39.
and pCMVhly were generated by replacing b-gal of pCMVb by the
PCR fragments. Immunoprecipitations
5 3 105 adherent PECs were infected with z5 3 106 S. typhimurium
Immunization and Challenge aroA harboring pCMVb, incubated for 4 hr in medium with or without
Groups of 5±10 female BALB/c mice were fed with 30 ml of 10% antibiotics, and left at 378C for various periods of time. Cells were
sodium bicarbonate buffer containing 108 recombinant S. typhimu- then starved 30 min in methionine-free medium and pulsed with 100
rium aroA strain harboring one of the eukaryotic expression vectors mCi [35S]methionine for 2 hr. Immunoprecipitations were performed
or the prokaryotic b-gal expression plasmid pAH97 (Holtel et al., with anti-b-gal antibodies (Promega) and analyzed on 8% SDS±
1992). Mice received either a single immunization or four immuniza- PAGE followed by fluorography. Into some samples, a 100-fold ex-
tions at 14-day intervals. Serum samples from both groups of mice cess of b-gal protein was added before addition of anti-b-gal anti-
were obtained on days 21, 7, 21, 35, and 63. Mice of each group bodies to determine the specificity of the precipitation.
were sacrificed at weeks 3, 5, 7, and 11 after the first immunization
and tested for T-cell responses. For protection studies, immunized
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